| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
54,218 |
41,502 |
$10.49M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
124,195 |
89,625 |
$6.35M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
56,337 |
52,950 |
$2.65M |
| 87428 |
|
38,494 |
37,843 |
$2.06M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,893 |
5,260 |
$1.91M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,767 |
24,527 |
$1.75M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
39,807 |
29,096 |
$1.66M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,181 |
7,097 |
$847K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
26,797 |
26,223 |
$459K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
858 |
841 |
$382K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,153 |
1,116 |
$274K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,076 |
5,994 |
$229K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,135 |
4,564 |
$223K |
| 71045 |
Radiologic examination, chest; single view |
6,975 |
6,368 |
$220K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
26,769 |
23,295 |
$192K |
| 87070 |
|
12,999 |
12,799 |
$183K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,462 |
407 |
$182K |
| G0378 |
Hospital observation service, per hour |
260 |
239 |
$180K |
| 80053 |
Comprehensive metabolic panel |
15,128 |
13,676 |
$148K |
| 01967 |
Neuraxial labor analgesia/anesthesia for planned vaginal delivery |
736 |
690 |
$146K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,892 |
6,793 |
$111K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
28 |
28 |
$99K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,998 |
1,928 |
$95K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,486 |
1,403 |
$90K |
| 87081 |
|
8,023 |
7,937 |
$86K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,834 |
1,755 |
$84K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,834 |
1,756 |
$84K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,462 |
1,432 |
$81K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
19,977 |
16,440 |
$81K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
120 |
115 |
$79K |
| 99215 |
Prolong outpt/office vis |
645 |
627 |
$76K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
804 |
688 |
$63K |
| 80061 |
Lipid panel |
5,926 |
5,872 |
$58K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,033 |
994 |
$46K |
| 84439 |
|
4,184 |
4,123 |
$45K |
| 83880 |
|
2,336 |
2,046 |
$45K |
| 87807 |
|
2,221 |
2,185 |
$44K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
331 |
317 |
$44K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,448 |
6,233 |
$42K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
866 |
558 |
$39K |
| 93017 |
|
71 |
68 |
$36K |
| 71046 |
Radiologic examination, chest; 2 views |
1,152 |
1,124 |
$32K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,415 |
1,373 |
$32K |
| 76801 |
|
340 |
284 |
$30K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
719 |
640 |
$30K |
| 84484 |
|
4,068 |
2,629 |
$30K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
108 |
82 |
$29K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,474 |
2,441 |
$27K |
| 81001 |
|
8,686 |
8,138 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
755 |
745 |
$24K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
130 |
123 |
$22K |
| 59025 |
Fetal non-stress test |
367 |
328 |
$22K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,868 |
3,653 |
$22K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,285 |
4,243 |
$21K |
| 73110 |
|
290 |
236 |
$21K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
198 |
151 |
$20K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
325 |
321 |
$19K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
574 |
568 |
$18K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
766 |
685 |
$18K |
| 83525 |
|
912 |
900 |
$17K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
420 |
416 |
$15K |
| 87420 |
|
611 |
593 |
$15K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,100 |
1,092 |
$14K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
763 |
750 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,708 |
2,461 |
$13K |
| 88142 |
|
641 |
603 |
$12K |
| 71250 |
|
158 |
154 |
$12K |
| 81025 |
|
1,377 |
1,320 |
$11K |
| 90785 |
|
230 |
227 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,927 |
2,493 |
$11K |
| J2785 |
Injection, regadenoson, 0.1 mg |
28 |
28 |
$11K |
| 73630 |
|
342 |
300 |
$11K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
497 |
429 |
$10K |
| 76642 |
|
121 |
85 |
$10K |
| 97161 |
|
68 |
68 |
$10K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
42 |
41 |
$10K |
| 80055 |
|
142 |
141 |
$10K |
| 81003 |
|
4,309 |
4,094 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
103 |
100 |
$9K |
| 84403 |
|
210 |
201 |
$9K |
| 76770 |
|
41 |
38 |
$9K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
20 |
12 |
$9K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
30 |
30 |
$9K |
| 84402 |
|
204 |
197 |
$8K |
| 83690 |
|
1,753 |
1,603 |
$8K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
42 |
41 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
929 |
785 |
$8K |
| 76641 |
|
94 |
64 |
$8K |
| 95816 |
|
25 |
24 |
$8K |
| 73030 |
|
321 |
294 |
$8K |
| 80076 |
|
932 |
921 |
$8K |
| 84702 |
|
650 |
483 |
$7K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
326 |
322 |
$7K |
| 87430 |
|
400 |
394 |
$7K |
| 95819 |
|
15 |
14 |
$7K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
61 |
27 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
117 |
113 |
$7K |
| 73130 |
|
123 |
101 |
$6K |
| 73610 |
|
165 |
145 |
$6K |
| 87186 |
|
1,438 |
1,306 |
$6K |
| 84460 |
|
1,750 |
1,714 |
$6K |
| 84450 |
|
1,657 |
1,622 |
$5K |
| 80047 |
|
998 |
966 |
$5K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
27 |
26 |
$5K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
13 |
13 |
$5K |
| 85610 |
|
2,178 |
1,802 |
$5K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
178 |
178 |
$5K |
| 0001A |
|
257 |
257 |
$5K |
| 93971 |
|
67 |
65 |
$5K |
| 93296 |
|
402 |
401 |
$5K |
| 83605 |
|
699 |
538 |
$5K |
| 87040 |
|
830 |
407 |
$4K |
| 86140 |
|
1,273 |
1,205 |
$4K |
| 83002 |
|
134 |
130 |
$4K |
| 80050 |
General health panel |
44 |
44 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
52 |
45 |
$4K |
| 82043 |
|
1,333 |
1,322 |
$4K |
| 86850 |
|
98 |
94 |
$4K |
| 84703 |
|
444 |
414 |
$3K |
| 83001 |
|
115 |
111 |
$3K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
39 |
37 |
$3K |
| 83735 |
|
1,232 |
1,072 |
$3K |
| 84270 |
|
87 |
87 |
$3K |
| 82607 |
|
642 |
641 |
$3K |
| 82947 |
|
443 |
438 |
$3K |
| 82670 |
|
70 |
67 |
$3K |
| 0002A |
|
126 |
126 |
$3K |
| 82977 |
|
536 |
510 |
$3K |
| 82570 |
|
1,322 |
1,309 |
$3K |
| 20610 |
|
99 |
92 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
91 |
91 |
$3K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
798 |
729 |
$3K |
| 82150 |
|
581 |
550 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,462 |
1,268 |
$2K |
| 87077 |
|
686 |
631 |
$2K |
| 73560 |
|
101 |
90 |
$2K |
| 85730 |
|
812 |
745 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
106 |
88 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
93 |
68 |
$2K |
| 92250 |
|
147 |
146 |
$2K |
| 83721 |
|
455 |
452 |
$2K |
| 82728 |
|
414 |
409 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
78 |
39 |
$2K |
| 82274 |
|
68 |
68 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
27 |
26 |
$2K |
| 80305 |
|
152 |
147 |
$2K |
| 82726 |
|
45 |
45 |
$2K |
| 73564 |
|
17 |
14 |
$2K |
| 86803 |
|
244 |
241 |
$2K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
25 |
13 |
$1K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
127 |
109 |
$1K |
| 82247 |
|
555 |
511 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
222 |
216 |
$1K |
| 82040 |
|
580 |
550 |
$1K |
| 82016 |
|
45 |
45 |
$1K |
| 84145 |
|
75 |
66 |
$1K |
| 83550 |
|
459 |
456 |
$1K |
| 85652 |
|
956 |
907 |
$1K |
| 84075 |
|
482 |
455 |
$1K |
| 82128 |
|
45 |
45 |
$1K |
| 83540 |
|
547 |
544 |
$1K |
| 82565 |
|
595 |
586 |
$1K |
| 87340 |
|
123 |
117 |
$1K |
| 73502 |
|
84 |
82 |
$1K |
| 87088 |
|
272 |
264 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,063 |
869 |
$994.83 |
| 87210 |
|
95 |
93 |
$949.17 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
16 |
12 |
$926.90 |
| 83993 |
|
25 |
25 |
$904.66 |
| 73140 |
|
13 |
12 |
$865.84 |
| 11721 |
|
68 |
67 |
$863.23 |
| 94760 |
|
21 |
13 |
$862.13 |
| 84155 |
|
485 |
456 |
$843.07 |
| 86900 |
|
417 |
385 |
$774.66 |
| 82784 |
|
52 |
49 |
$767.50 |
| 82077 |
|
56 |
52 |
$767.41 |
| 86901 |
|
398 |
369 |
$747.75 |
| 43248 |
|
12 |
12 |
$737.20 |
| 83516 |
|
32 |
25 |
$690.90 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
73 |
58 |
$684.62 |
| 86038 |
|
95 |
89 |
$682.63 |
| 88342 |
|
45 |
40 |
$655.40 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
25 |
25 |
$649.61 |
| 86364 |
|
89 |
48 |
$619.56 |
| 84305 |
|
13 |
13 |
$508.66 |
| 86258 |
|
63 |
33 |
$460.68 |
| 92551 |
|
29 |
29 |
$420.89 |
| 87205 |
|
163 |
134 |
$393.31 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
13 |
13 |
$389.16 |
| 80320 |
|
21 |
14 |
$386.85 |
| 29075 |
|
12 |
12 |
$359.66 |
| 86592 |
|
62 |
61 |
$326.01 |
| 84132 |
|
152 |
135 |
$306.25 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
43 |
28 |
$303.05 |
| 72100 |
|
28 |
26 |
$302.91 |
| 82962 |
|
5,279 |
1,835 |
$286.22 |
| 82950 |
|
32 |
32 |
$245.79 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
565 |
505 |
$236.82 |
| 96127 |
|
109 |
109 |
$220.44 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
14 |
14 |
$216.36 |
| 83520 |
|
13 |
13 |
$213.89 |
| 36415 |
Collection of venous blood by venipuncture |
11,971 |
10,693 |
$181.08 |
| 96160 |
|
36 |
36 |
$178.59 |
| 85379 |
|
28 |
28 |
$176.28 |
| 73552 |
|
14 |
13 |
$167.08 |
| 90837 |
Psychotherapy, 53 minutes with patient |
15 |
12 |
$156.08 |
| 82550 |
|
42 |
36 |
$154.98 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13 |
13 |
$150.71 |
| 11056 |
|
12 |
12 |
$148.10 |
| 90686 |
|
130 |
129 |
$117.18 |
| 83718 |
|
12 |
12 |
$107.72 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
79 |
75 |
$105.26 |
| 92134 |
|
40 |
40 |
$92.06 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
45 |
45 |
$90.24 |
| 90836 |
|
14 |
12 |
$87.27 |
| 0012A |
|
65 |
65 |
$80.00 |
| 84478 |
|
12 |
12 |
$77.90 |
| 77080 |
|
24 |
24 |
$77.53 |
| 86706 |
|
13 |
13 |
$72.90 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
16 |
15 |
$70.24 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
35 |
24 |
$68.01 |
| 86431 |
|
27 |
27 |
$65.02 |
| 87147 |
|
14 |
13 |
$61.04 |
| 82465 |
|
12 |
12 |
$58.73 |
| 0011A |
|
155 |
155 |
$56.94 |
| 85018 |
|
101 |
90 |
$50.83 |
| 96376 |
|
301 |
193 |
$46.65 |
| 0004A |
|
38 |
38 |
$40.00 |
| 85014 |
|
74 |
65 |
$25.50 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
38 |
37 |
$10.17 |
| 84550 |
|
12 |
12 |
$9.66 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
475 |
446 |
$0.39 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
180 |
142 |
$0.06 |
| 36416 |
|
314 |
309 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
32 |
27 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
254 |
254 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
25 |
24 |
$0.00 |
| C1769 |
Guide wire |
29 |
27 |
$0.00 |
| J3490 |
Unclassified drugs |
81 |
64 |
$0.00 |
| A9150 |
Non-prescription drugs |
13 |
12 |
$0.00 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
1,991 |
1,816 |
$0.00 |
| 90662 |
|
127 |
127 |
$0.00 |
| 36592 |
|
58 |
27 |
$0.00 |